NBCD A/S: Financial statements 2025
CVR: 30582462
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
NBCD A/S (CVR 30582462) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. That is a decrease of 71.6% compared with the year before. Equity in the 2025 report amounted to DKK 136,144,994. The solvency ratio was 40%. The company had 33 employees in the financial year.
- Gross Profit
- DKK 31,583,144
- Profit/Loss
- DKK 9,222,892
- Equity
- DKK 136,144,994
- Total Assets
- DKK 340,184,147
- Employees
- 33
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 31.6 mio. | 9.2 mio. | 136.1 mio. | 33 |
| 2024 | - | 111.2 mio. | 52.6 mio. | 176.9 mio. | 31 |
| 2023 | - | 133.7 mio. | 70.8 mio. | 194.3 mio. | 31 |
| 2022 | - | 94.7 mio. | 45.9 mio. | 123.5 mio. | 23 |
| 2021 | - | 60.4 mio. | 35.6 mio. | 107.6 mio. | 20 |
Official annual report
How creditworthy is NBCD A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 31, 2025, Jakob Brix Christensen has stepped down as director of NBCD A/S.
NBCD A/S has published its annual report for 2024. Gross profit came to DKK 111,159,954, and the net result was DKK 52,621,101.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The board consists of Pierre Khaitrine (chair), Jeppe Ragnar Andersen and José Ignacio Pfeifer. The company is owned by Sanos Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity in the 2025 report amounted to DKK 136,144,994.